Porcine teschoviruses (PTVs) constitute 1 of the 31 genera within the Picornaviridae family, comprising at least 13 genetic types (PTV-1 to PTV-13), of which only 11 (PTV-1 to PTV-11) have been recognized as serotypes to date. Specific for swine and wild boars, most PTVs are usually non-pathogenic, but some viral variants cause severe disorders in the central nervous system (Teschen disease) or milder signs (Talfan disease), as well as reproductive, digestive and respiratory disorders and skin lesions. Previous studies revealed a high diversity of teschoviruses circulating in Spanish pig populations. Phylogenetic analysis performed with these sequences and others available in GenBank disclosed 13 clusters, 11 of which corresponded to the known PTV serotypes, and 1 of 2 additional groups is represented by isolate CC25, whose full-length genomic sequence has been obtained. This group is new to science, and was putatively named PTV-12. Here, a complete characterization of this isolate is presented, including the experimental infection of minipigs to assess tissue tropism and possible pathogenicity in vivo in the host species. In addition, using this experimental animal model, we investigated whether a pre-existing infection with this PTV-12 isolate could confer cross-protection against infection with a heterotypic PTV-1 virulent strain. Based on phylogenetic analysis and serological data, we propose CC25 as the prototype strain of a new teschovirus serotype, PTV-12.
INTRODUCTION
Teschovirus A (Teschovirus genus, Picornaviridae family) is a diverse virus species specifically infecting swine and wild boars. The available serological data indicate 11 different porcine teschovirus (PTV) serotypes, named PTV-1-11, corresponding to the 11 described genotypes [1] . Like other picornaviruses, PTVs exhibit round-shaped non-enveloped virions that are approximately 30 nm in diameter, with a capsid shell comprising four structural proteins (VP1 to VP4). The viral genome consists of one single-stranded RNA molecule of approximately 7100 nucleotides, encoding a single polyprotein that is cleaved proteolytically upon translation to yield functional viral polypeptides. PTVs are enteric viruses, transmitted by the faecal-oral route. Once acquired orally, they infect primarily epithelial cells from the gastrointestinal tract, replicating in tonsils, intestinal and lymphoid tissues, from where they can reach other target tissues and organs [2] . Upon replication in the gut, PTVs are shed in faeces in large quantities, back to the environment, where they show considerable stability and persist for a long time, hence constituting an important source for further infections [3] . Most PTV infections remain asymptomatic in their known natural hosts, pigs and wild boars. However, occasionally (and mostly associated with either virulent strains or non-immunocompetent hosts, or both) the virus invades the central nervous system (CNS) via the haematogenous or vascular route, crossing the blood-brain barrier and triggering a non-suppurative encephalitis that causes neurological disorders, which can be severe (a condition called enterovirus encephalomyelitis or Teschen disease) or mild (Talfan disease), and are characterized by fever and anorexia (not always), opisthotonos, nystagmus, locomotive disorders (hypersensitivity, tremors, clonic spasms and ataxia), convulsions, paresis and/or flaccid paralysis of the IP: 54.70.40.11
On: Sat, 20 Apr 2019 23:38: 22 hindquarters progressing to total paralysis [4] . Other clinical manifestations of PTV infections comprise reproductive failure, respiratory disorders such as rhinitis and pneumonia, enteral disease, such as diarrhoea, myocarditis, pericarditis and dermic lesions [5] . The disease was considered to be of economic importance in the past, being classified in the World Organization for Animal Health (OIE) disease list B, until it was removed in 2004, as the disease became infrequent. Nevertheless, PTV outbreaks of importance have been reported in Haiti and China recently [6, 7] . Different surveillance studies have revealed that non-pathogenic PTV infections are ubiquitous in pig farms and concurrent infections caused by distinct serotypes are often observed. Furthermore, co-infections in the same individual are a frequent event [8] [9] [10] [11] [12] [13] . This widespread distribution of PTVs in domestic pigs, along with their presence in faeces and faecally contaminated matter, and their stability in the environment, has led to them being proposed as optimal markers for environmental contamination of porcine faecal origin [14] .
Recent findings suggest that PTV diversity is higher than is represented by the 11 serotypes previously recognized. On the one hand, a survey on PTVs in faecal samples of asymptomatic pigs in Spain uncovered a new and differentiated cluster of isolates putatively named PTV-12 [11] . A comprehensive sequence and phylogenetic analysis of a representative isolate from this cluster corroborated that it was different from all known PTV serotypes [15] . Also, pyrosequencing (massive sequencing) studies in asymptomatic wild boars in Hungary found a new teschovirus genotype tentatively named PTV-13 [16] . On the other hand, an epidemiological investigation carried out from faecal specimens of piglets in China proposed a new type that clusters separately from the 13 possible genotypes published to date [17] . The full characterization of these genotypes that is necessary for their recognition as new teschovirus serotypes, is still pending. In the present study a representative virus isolate belonging to the putative PTV-12 group was characterized in depth, including its serological relatedness with other PTV serotypes, while its pathogenicity and tissue tropism were determined via experimental inoculation in a competent host. Finally, the possible existence of cross-protection with regard to heterologous PTV-1 was also explored.
RESULTS
Antibody response and serological characterization of CC25 isolate In order to establish the essential parameters of the humoral antibody response raised by CC25 in the hosts, neutralizing antibodies (NtAbs) were monitored in serum for 21 days after inoculation. All inoculated pigs (#3 to #8) developed a humoral immune response, starting with the rise of detectable NtAbs in serum at 4 days post-inoculation (p.i.). Full seroconversion in all infected pigs was observed at 7 days p. i., reaching an average NtAb titre of 1 : 1240 at 14 days p.i. that decreased slightly between 17 and 21 days p.i. control animals (#9, #10 and #11) remained negative throughout the whole sampling period (Fig. 1a) .
With the aim of showing that the neutralizing antibody (NtAb) response for CC25 was serotype-specific and distinct from that of the other known serotypes, the NtAb titres of a panel of monospecific antisera raised as a reference and field strains of the different PTV serotypes and other related enteric viruses were measured against CC25. As a result, the neutralization titres observed for the antisera raised as heterologous strains were always much lower (i.e. 1 : 40 or lower) as compared to the titre observed for each of the homologous strains (Table 1 ). These results demonstrated that none of the assayed antisera were able to specifically neutralize the CC25 isolate. As long as PTV-10 was not represented in the panel of antisera used in this analysis, we proceeded conversely in order to demonstrate that CC25 is also distinct from this serotype. Here, two sera obtained from pigs #6 and #8 at 14 days p.i. showed titres of 1 : 2560 and 1 : 640, respectively, against the homologous (CC25) isolate, whereas the titres in both cases fell to 1:80 against the heterologous PTV-10 strain (12/15Ge).
These results show that the neutralizing antibody response for CC25 is serotype-specific and distinguishable from that elicited by the other PTV serotypes described to date.
Viremia, secretion, tropism and pathogenicity of CC25 isolate With the aim to study the nature and course of the infection, and to examine any possible disease sign caused by CC25 in the pig host, clinical and analytical parameters were monitored for 21 days after inoculation. No disease signs were observed in any of the inoculated pigs during the experiment, confirming the lack of pathogenicity of CC25 in the experimental conditions employed in this study. The viral genome was only detected weakly in the bloodstream of one inoculated pig at 2 days p.i. (#7, Ct=38.17, Table 2 ), while the blood of all the other pigs remained negative during the whole experiment. This observation indicated a faint, transient viremia at the early stages after infection. As for virus shedding, oral swabs were found to be positive for virus detection at 2, 4 and 7 days p.i. in all inoculated pigs, and also transiently at 14 days p.i. in two of them. Although the remains of inoculum (administered orally) could not be discarded as a cause of the positive results obtained in oral swabs, especially at the earliest sampling time (2 days p.i.), it is more likely that these results arise from virus shed in the saliva as a result of the infection, as the virus primarily replicates in tonsils after oral inoculation and is excreted by saliva, and thus viral load in saliva in the first days post-infection is expected. Further, growing amounts of shed virus at 4 days p.i. in most infected pigs supports this argument. Faecal samples from CC25-inoculated pigs showed that the virus was being shed continuously through faeces. The control group remained negative throughout the follow-up period, except for one pig (#10) that transiently shed teschovirus in faeces from 0 to 7 days p.i. In addition, one pig (#3) of the inoculated group also shed teschovirus in faeces at 0 days p.i. (that is, before the inoculation) ( Table 2 ). These samples (#3 at 0 days p.i. and #10 at 0 to 7 days p.i.) were subjected to independent re-extraction and RRT-PCR analysis, which confirmed these findings. Furthermore, sequence analyses of the partial VP2 proteincoding gene from the PTV-positive faecal sample of pig #10 at 4 days p.i. revealed a previous cryptic infection with a teschovirus that was different from those employed in this work, since it showed higher homology (89 %) with the PTV-1 Teschen-199 strain. Thus, this result indicated that at least some of the pigs studied could have had cryptic PTV infections prior to the experiment, despite being subjected to PTV screening and having been shown to be negative by molecular detection and serological techniques prior to their recruitment for this study.
Analysis of tissues in pigs #3 and #4, slaughtered at 14 and 21 days p.i., respectively, revealed the presence of the virus mainly in the digestive tract and lymphoid system, while it was not detected in the CNS or in other organs. Unexpectedly, one of the non-inoculated control pigs (#9), necropsied at 21 days p.i., tested positive for teschovirus genome in Peyer's patches, despite showing negative results in faeces, blood and oral swabs throughout the whole experiment ( Table 3) . A second re-extraction and RRT-PCR analysis of this sample showed identical results. Given the special measures adopted to avoid cross-contamination (see the Methods section), accidental contamination of this sample seems highly unlikely, although it cannot be ruled out. To assess whether this single result could arise from an unnoticed, cryptic, persistent infection of pig #9 by a different teschovirus acquired before the experiment, analogously to what was found in the faecal samples from pig #10, attempts were made to obtain sequence data from this sample. However, they were unsuccessful.
Histopathological studies on CNS tissues failed to show any alteration compatible with non-suppurative encephalomyelitis, a typical inflammatory process of the neurotropic stage of Teschen-Talfan disease. However, the mesenteric lymph nodes of CC25-inoculated pigs (#3 and #4) showed a lymphoid follicular hyperplasia with an increasing quantity of lymphoblasts, without analogous findings in a control pig (#9). Further, Peyer's patches in both CC25-inoculated pigs revealed a progressive reaction in the lymphoid follicles while showing a discrete reaction in the control pig. Histopathological study of the tonsils and gastrointestinal tract (stomach, duodenum and colon) failed to show significant differences between CC25-inoculated and control pigs (not shown). Overall, these results show that CC25 infection was successfully reproduced in the inoculated pigs, in which it proceeded asymptomatically in the conditions of the assay.
Cross-protection against heterotypic serotype A challenge experiment was performed with the aim of testing whether CC25 infection confers cross-protection against a subsequent infection with a heterologous PTV serotype, comparing non-CC25 inoculated (i.e. naïve) pigs. First, the inoculation of two naïve pigs (#10 and #11) with TeschenTirol strain (PTV-1) (Table 4 ) triggered an infection in both, which responded with high titres of NtAbs to the homologous PTV-1 strain at 7 days p.i. (28 days p.i. with respect to the experimental starting date), reaching an average titre of 1 : 960 at 10 days p.i., which remained stable during the whole study (Fig. 1b) . These sera did not cross-react with CC25 isolate, as the NtAb titres observed against this heterologous strain were 1 : 10 ( Fig. 1a) , thus confirming the lack of cross-reaction between the serotypes. On the other hand, four of the pigs infected with CC25 isolate (#5 to #8) were inoculated at 21 days p.i. with the same infectious dose of Teschen-Tirol strain as was used for the naïve pigs. Seroconversion occurred at 7 days after this second inoculation (28 days after the first inoculation with CC25, i.e. on the 28 th day of the complete assay), reaching an average titre of 1 : 1040 at 10 days after the second infection (the 31 st day of the complete assay) and maintaining these titres until the end of the assay (50 days) (Fig. 1b) .
In the group inoculated first with CC25 PTV-12 isolate and subsequently with Teschen-Tirol PTV-1 strain (Table 4) , the level of antibodies against CC25 did not change after the (-), no data.
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second infection (Fig. 1b) , corroborating the absence of serological interference between these two serotypes. Moreover, the humoral immunity raised against CC25 proved to be highly stable and long-lasting, at least up to 50 days p.i.
(the end of the experiment), with an average titre of 1 : 880 (Fig. 1a) . Consequently, prior infection with CC25 isolate did not prevent infection with the Teschen-Tirol strain, since all the pigs within this group developed an infection caused by the newly inoculated strain, raising antibodies to this strain with similar kinetics and potency to those observed for the naïve pigs. No disease signs were observed in the pigs inoculated with Teschen-Tirol strain during this study, either if previously infected with CC25 or not, thus confirming the lack of pathogenicity of the Teschen-Tirol strain in the experimental conditions applied.
Phylogenetic analysis of CC25 isolate A phylogenetic analysis was performed to assess and update the genetic relationships between the different PTV strains and serotypes with the available sequence data. Phylogenetic analysis of P1 polyprotein clustered the sequences into 13 distinct groups, corroborating that the CC25 isolate forms a new genotype among the Teschovirus genus, with the proposed name PTV-12 (Fig. 2) .
DISCUSSION
Most known teschovirus strains are non-pathogenic, although occasionally neurovirulent strains arise associated with severe non-suppurative encephalomyelitis [5] . Co-circulation of different serotypes in a geographic area [7, [10] [11] [12] , and co-infection of at least two different PTV serotypes in the same animals or herds [11, 13] , are common observations that may rely on two important characteristics of these viruses: their high persistence in the environment and their abundance in domestic pigs and wild boars. The long-lasting persistence observed for PTVs may support the emergence of viable recombinants by cellular co-infection of viral variants. Thus both driving forces of viral evolution, recombination and mutation, seem to contribute to the viral diversity in Teschovirus genus [11, 18, 19] .
In a previous study, homology analysis of the CC25 fulllength coding genome sequence revealed that its P1-coding region exhibits the highest identity to strains of serotypes 2, The lack of pathogenicity observed for CC25 in an experimental pig model is in agreement with its original isolation from healthy pigs. Further, non-pathological changes and the absence of teschovirus genome in the CNS confirm that CC25 strain was not able to cross the blood-brain barrier after infection by the oral route, which is its natural means of entry into the body, thereby confirming the non-pathogenic nature of PTV-12, at least in the employed experimental conditions. Interestingly, Yamada and colleagues, using teschovirus strain Toyama/2002, obtained different results, depending on the route of inoculation; while the intravenous route caused a non-suppurative encephalomyelitis with neurological clinical signs, no lesions of the CNS were induced in pigs by oral or intranasal inoculations [20] .
The results obtained in the present study indicated that some of the pigs were persistently infected with PTV, a situation that went unnoticed in preliminary testing, since all the pigs used in the experiment were tested at the farm of origin for teschovirus presence by RRT-PCR in blood, oral and faecal samples and proved to be negative. In this regard, asymptomatic PTV infections are widespread in domestic pigs from wide geographic areas, including Spain, which is where these pigs came from [9] . Therefore, latent infections in some of the pigs, leading to transient virus shedding in faeces triggered by the stress caused by transport, new housing and/or other conditions, could not be ruled out. The influence of this fact on the outcome of the experimental work described in this paper is difficult to evaluate. Diverse studies have recently pointed out that PTV endemic situations are rather common, with there being high prevalence for teschoviruses in pig populations from a wide geographic range [19, 21, 22] . Furthermore, non-pathogenic strains are frequently isolated from domestic pigs. All these facts might indicate that persistent infections with PTVs could easily arise in these conditions, which means that obtaining teschovirus-free pigs for experimental work on PTVs might be a difficult task, and a limitation for this type of experimental work. A possible solution would be to use of gnotobiotic pigs as models for further study of PTV pathogenesis [23] .
Likewise, in the present work the strain Teschen-Tirol did not induce either observable lesions in the CNS or nervous symptomatology, whereas in a previous study this same strain was shown to be neuropathogenic in experimentally infected pigs [24] . Factors like storage conditions, or the passage history of the actual virus inoculated in this study, might influence this outcome. Since its isolation in 1961, Teschen-Tirol strain has been passaged and stored in conditions whose details unfortunately are barely known. In spite of this, the serological results observed in the present study clearly indicated that the immune response triggered by a previous infection with strain CC25 will not protect against a subsequent infection by the serotype 1 TeschenTirol strain, a fact reflecting the heterotypic relationship between both strains and further supporting that CC25 represents a distinct serotype that is different from serotype 1. Finally, Chiu and colleagues, using the faecal-oral model of pathogenesis, demonstrated that in endemically infected pigs the virus is most commonly detected in the intestines and lymphoid organs, and less commonly in visceral organs and the CNS [13] . These findings are fairly consistent with the results presented here, which indeed highlight the fact that the CNS and visceral organs are uncommon targets for PTV infections, at least under the conditions of this study.
In conclusion, based on a complete biological characterization, this study further demonstrates that the CC25 strain represents a new teschovirus serotype, tentatively named serotype 12.
METHODS
Cell culture and propagation of isolates The isolate CC25, from an apparently healthy pig, was grown in the IB-RS 2 cell line following standard procedures for the propagation of enteric viruses. Briefly, each 25 cm 2 cell culture flask containing 90 % confluent IB-RS 2 cell monolayer was inoculated with 1 ml of a clarified cell-culture supernatant rich in CC25 strain. Viral adsorption was allowed for 1 h 30 min at 37 C, with gentle agitation every 15-20 min. After that, the inoculum was removed and the infected cell monolayer was supplemented with Dulbecco's modified Eagle's medium (DMEM) with 2 % of foetal bovine serum (FBS) plus antibiotics (penicillin-streptomycin). The incubation was performed at 37 C and 5 % CO 2 until a characteristic CPE was observed at 48-72 h. Infected cell cultures were clarified by gentle centrifugation (600 x g for 10 min at 4 C), aliquoted and preserved at À70 C. The isolate CC25 was subjected to five passages in cell culture and subsequently titrated by the standard end-point dilution method [25] . The Teschen-Tirol strain (PTV-1) used in the present study was obtained from the Department of Virology and Antiviral Therapy (Jena University Hospital, Germany). It was propagated in PS-EK cells and titrated by the same standard method.
Animals and experimental design Nine 14-week-old minipigs (Sach pigs) from a breeding farm of experimental pigs belonging to Instituto Madrileño de Investigación y Desarrollo Rural Agrario y Alimentario (IMIDRA) were used in the assays. The animals had been selected according to their negative serology against CC25 and Teschen-Tirol strains (analysed by SNT) and the absence of viral genome detection in blood, oral and faecal samples by RRT-PCR [26] . The pigs were divided into two groups (G-1 and G-2) and housed separately to prevent cross-infection. The first group (individuals #3 to #8) were inoculated orally with 3 ml of 10 7.0 TCID 50 of PTV isolate CC25 each, and housed for 21 days. The other group (G-2), comprising three pigs (#9 to #11), was used as the control, and was kept in separate housing and sham-inoculated with mixed uninfected cell-culture supernatants (IB-RS 2 /PS-EK). At 21 days after inoculation, four pigs belonging to the first group (G-1, pigs #5 to #8) and two pigs from the second group (G-2, pigs #10 and #11) were challenged orally with 3 ml of 10 7.0 TCID 50 of Teschen-Tirol (PTV1) strain and kept in the same housing as above for another 29 days (Table 4 ).
The pigs were examined clinically at daily intervals, and samples (whole blood, serum, oral swabs and faeces) were collected at 0, 2, 4, 7, 10, 14, 17 and 21 days after the first infection with CC25. Upon challenge with Teschen-Tirol strain, only serum samples were collected, at 0, 2, 4, 7, 10, 14, 17, 21 and 29 days post-challenge. During the sampling operations, the pigs were anaesthetized intramuscularly with tiletamine-zolazepam hydrochloride (10 mg/kg) and atropine sulfate (0.4 mg/kg). Necropsies were scheduled at 14 days p.i. (pig #3) and 21 days p.i. (pigs #4 and #9). At the end of the experiment (50 days post-challenge), the remaining animals, previously sedated, were humanely euthanized by injection of sodium pentobarbital (200 mg/kg, administered intravenously). Sampling was carried out in a systematic way, employing strict measures intended to prevent cross-contamination between groups (e.g. samples of the negative controls were collected first in a separate box; the boxes containing samples from the different animal groups were opened independently in a biological class II laminar flow safety cabinet, with the negative controls always being handled first, and sterile single-use materials being used to collect each sample, following the principles of good laboratory practice). The animals were maintained in a BSL3 facility according to the CISA guidelines and used in protocols supervised and approved by the Ethics and Animal Welfare Committees of the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) in agreement with the rules in place in the EU (directive 63/2010).
Phylogenetic analysis of viral P1 region
Multiple alignment of 77 complete polyprotein P1 sequences of diverse PTVs available in GenBank, including that from the CC25 strain, as previously published [15] , followed by statistical selection of a best-fit model for nucleotide substitution, were carried out using specialized software (ClustalX and jModelTest). Phylogenetic reconstruction was performed using the maximum likelihood statistical method, conducted by Mega 5.05. The topology that gave the highest maximum likelihood was chosen as the final tree (Fig. 2 ).
Viral load analysis by real-time RT-PCR and molecular characterization. Total RNA was automatically extracted from 100 µl of blood, oral swab and faeces or tissue sample homogenates (diluted to 1/10 in PBS) using the Biosprint 15 workstation (Qiagen) and the BioSprint DNA blood kit (Qiagen), according to the manufacturer's protocol. RNA was eluted in a final volume of 100 µl RNase-free water and stored at À20 C until further analysis. RNA samples were analysed by real-time RT-PCR (RRT-PCR), as described previously
